Back
Neurocrine Biosciences Stock Price Chart
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Buy
68
NBIX
Neurocrine Biosciences
Last Price:
137.49
Seasonality Move:
8.72%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 136.26 | Buy |
| 20-day SMA: | 136.36 | Buy |
| 50-day SMA: | 136.66 | Buy |
| 200-day SMA: | 121.6 | Buy |
| 8-day EMA: | 136.92 | Buy |
| 20-day EMA: | 136.68 | Buy |
| 50-day EMA: | 136.14 | Buy |
| 200-day EMA: | 124.69 | Buy |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 54.78 | Buy |
| Chaikin Money Flow: | 482211 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (134.17 - 139.87) | Buy |
| Bollinger Bands (100): | (127.7 - 140.68) | Buy |
Neurocrine Biosciences Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 138.89 while NBIX 8-day simple moving average is 136.26, which is a Buy signal.
- The stock price of NBIX is 138.89 while Neurocrine Biosciences 20-day SMA is 136.36, which makes it a Buy.
- Neurocrine Biosciences 50-day simple moving average is 136.66 while NBIX share price is 138.89, making it a Buy technically.
- NBIX stock price is 138.89 and Neurocrine Biosciences 200-day simple moving average is 121.60, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
68
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a Buy
The current Neurocrine Biosciences [NBIX] share price is $138.89. The Score for NBIX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
13.82B
Price in USD:
138.89
Share Volume:
678.37K
Neurocrine Biosciences 52-Week Range
52-Week High:
148.37
52-Week Low:
89.04
Buy
68
Neurocrine Biosciences (NBIX)
is a Buy
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?
The Neurocrine Biosciences stock price is 138.89 USD today. -
Will NBIX stock go up or go down?
Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Neurocrine Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is not overvalued.
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 138.89 while NBIX 8-day exponential moving average is 136.92, which is a Buy signal.
- The stock price of NBIX is 138.89 while Neurocrine Biosciences 20-day EMA is 136.68, which makes it a Buy.
- Neurocrine Biosciences 50-day exponential moving average is 136.14 while NBIX share price is 138.89, making it a Buy technically.
- NBIX stock price is 138.89 and Neurocrine Biosciences 200-day simple moving average is 124.69, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.88 per share, and an increase next year of $1.78 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
- NBIX Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Neurocrine Biosciences is a Sell
- Neurocrine Biosciences Relative Strength Index (RSI) is 54.78, which suggest Neurocrine Biosciences is overbought
- The Bollinger Bands (25) for Neurocrine Biosciences is (134.17 - 139.87), which suggest Neurocrine Biosciences is a Buy
- The Bollinger Bands (100) for Neurocrine Biosciences is (127.7 - 140.68), which suggest Neurocrine Biosciences is a Buy
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.